ViroGates A/S (VIRO) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.879x

Based on the latest financial reports, ViroGates A/S (VIRO) has a cash flow conversion efficiency ratio of -0.879x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-2.49 Million ≈ $-389.89K USD) by net assets (Dkr2.83 Million ≈ $443.56K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ViroGates A/S - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how ViroGates A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VIRO liabilities breakdown for a breakdown of total debt and financial obligations.

ViroGates A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ViroGates A/S ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Overactive Media Corp V:OAM	-0.039x
Javelin Minerals Ltd AU:JAV	-0.059x
Turbo Mech Bhd KLSE:5167	0.038x
In8bio Inc NASDAQ:INAB	-0.217x
Nusantara Almazia JK:NZIA	0.007x
Marwynn Holdings, Inc. Common stock NASDAQ:MWYN	-0.332x
Elicera Therapeutics AB ST:ELIC	-0.156x
Vinpai SAS PA:ALVIN	3.105x

Annual Cash Flow Conversion Efficiency for ViroGates A/S (2015–2024)

The table below shows the annual cash flow conversion efficiency of ViroGates A/S from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is ViroGates A/S worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Dkr10.79 Million ≈ $1.69 Million	Dkr-11.95 Million ≈ $-1.87 Million	-1.107x	-54.56%
2023-12-31	Dkr17.01 Million ≈ $2.66 Million	Dkr-12.18 Million ≈ $-1.91 Million	-0.716x	+19.30%
2022-12-31	Dkr16.09 Million ≈ $2.52 Million	Dkr-14.28 Million ≈ $-2.23 Million	-0.887x	+32.01%
2021-12-31	Dkr16.43 Million ≈ $2.57 Million	Dkr-21.44 Million ≈ $-3.35 Million	-1.305x	-161.93%
2020-12-31	Dkr31.31 Million ≈ $4.90 Million	Dkr-15.60 Million ≈ $-2.44 Million	-0.498x	-16.38%
2019-12-31	Dkr42.22 Million ≈ $6.60 Million	Dkr-18.07 Million ≈ $-2.83 Million	-0.428x	-59.46%
2018-12-31	Dkr61.01 Million ≈ $9.55 Million	Dkr-16.38 Million ≈ $-2.56 Million	-0.268x	+87.07%
2017-12-31	Dkr3.00 Million ≈ $468.90K	Dkr-6.22 Million ≈ $-973.79K	-2.077x	-179.46%
2016-12-31	Dkr8.98 Million ≈ $1.41 Million	Dkr-6.68 Million ≈ $-1.04 Million	-0.743x	-60.13%
2015-12-31	Dkr14.39 Million ≈ $2.25 Million	Dkr-6.68 Million ≈ $-1.04 Million	-0.464x	--

About ViroGates A/S

CO:VIRO Denmark Medical Devices

Market Cap

$15.97 Million

Dkr102.10 Million DKK

Market Cap Rank

#25812 Global

#117 in Denmark

Share Price

Dkr11.00

Change (1 day)

+4.76%

52-Week Range

Dkr7.80 - Dkr17.40

All Time High

Dkr238.00